Use of recombinant human hematopoietic growth factors and autologous bone marrow transplantation to attenuate the neutropenic trough of high-dose therapy.

G Spitzer; A Deisseroth; G Ventura; S Jagannath; B Fogel; K Taylor; S Huan; F Dunphy; K Dicke; L Souza

doi:10.1002/stem.5530080723

Use of recombinant human hematopoietic growth factors and autologous bone marrow transplantation to attenuate the neutropenic trough of high-dose therapy.

Identifier:nobleid.org/w1/20260515/CB57ABB5

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CB57ABB5.svg?ark=w1%2F20260515%2FCB57ABB5)](https://nobleid.org/work/w1/20260515/CB57ABB5)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Use of recombinant human hematopoietic growth factors and autologous bone marrow transplantation to attenuate the neutropenic trough of high-dose therapy.

Identifier:nobleid.org/w1/20260515/CB57ABB5

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CB57ABB5.svg?ark=w1%2F20260515%2FCB57ABB5)](https://nobleid.org/work/w1/20260515/CB57ABB5)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work